IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
Life review of elderly depression
Development and application of ATR-FTIR spectroscopy for mixture homogeneity in pharmaceutical application
The Increasing Damage in Tubular Cell of Infant Mice’s Kidneys from Carbofuran Exposure during its Mothers’ Lactation Period
Trend of transsexualism problem and its implications towards muslim community in Malaysia
Development and validation of RP-HPLC method for the estimation of pidotimod in tablet dosage form
Evaluation of neurotoxicity of the ethanolic bark extract of Holarrhena pubescens Wall. ex G.Don in mice
Design, synthesis and evaluation of 2-aminobenzimidazole derivatives: strong candidate for PPAR gamma agonists.
Prediction of Heart Disease Using Feature Selection and Random Forest Ensemble Method
Strategies for Antiviral Drugs from Plants by Targeting the Hemagglutinin, Neuraminidase and other receptors of Influenza A virus
The impact of human resource and quality management in health care: A Review
12345678910...
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Study of Aminoacy lt RAN-SynthetaseComplex Interacting Multifunctional Protein 1 and Liver Enzymes in Iraqi Women with Breast Cancer Undergoing Chemotherapy

Author: EIMAN A., BAYADER ABDUL HUSSEIN
Abstract: Breast carcinoma is one of the greatest popular neoplasms in females. It is a major reason of demise in the world, and it is the first cancer in ranking diagnosed in Iraqi women. This study aimed to determine aminoacyltRAN-synthetase complex interacting multifunctional protein 1 and liver enzymes levels in Iraqi females with stage II breast malignance, and study the effect of chemotherapy (after surgery) on these markers. This study included 50 females patients with stage II breast malignance (before and after surgery and second dose of chemotherapy) attending the Oncology Teaching Hospital in Medical City/ Baghdad, in addition to 20 persons as controller group were chosen without any chronic diseases. Their ages ranged from (30-55) years. The results shown elevation inaminoacyltRAN-synthetase complex interacting multifunctional protein 1, CA15-3, liver function test levels, while there was a decrease in magnesium level in serum of females with stage II breast malignance before and after two dose chemotherapy when compared with the controls. The current revision is the first in follow-up of aminoacyltRAN-synthetasecomplex interacting multifunctional protein 1 level in serum of women patients with breast malignance before and after chemotherapy treatment. The aminoacyltRAN-synthetase complex interacting multifunctional protein 1may be a new bio-marker in breast malignance. Because the elevation in liver enzymes and decrease in magnesium levels, these patients may be more prone to liver damage, and the magnesium may be as a chemo-preventive agent from breast cancer because the inverse relationship between the magnesium and this disease.
Keyword: Breast cancer, Chemotherapy, AminoacyltRAN-synthetase complex interacting multifunctional protein 1.
DOI: https://doi.org/10.31838/ijpr/2019.11.04.002
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free